![Mark de Souza](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Mark P.
de Souza was the founder of NFlection Therapeutics, Inc., founded in 2014, where the title held was Executive Chairman from 2014 to 2022.
Dr. de Souza is also the founder of NF2 Therapeutics, Inc.,Chromaderm, Inc.,FIBRX Derm, Inc...
Dr. de Souza currently serves as Chief Executive Officer & Director at SeylanMED LLC, Chief Executive Officer at SeylanMED, Inc., President, Chief Executive Officer & Director at SonALAsense, Inc. since 2022, and Director at Phoenicis Therapeutics, Inc. Former positions include Executive Chairman at Wings Therapeutics, Inc.
Postes actifs de Mark de Souza
| Sociétés | Poste | Début |
|---|---|---|
FIBRX Derm, Inc.
 FIBRX Derm, Inc. Pharmaceuticals: MajorHealth Technology Develops anti-scarring therapeutic for patients with skin diseases | Fondateur | - |
SeylanMED LLC
 SeylanMED LLC Miscellaneous Commercial ServicesCommercial Services Develops a therapy for seborrheic keratosis | Directeur Général | - |
Chromaderm, Inc.
 Chromaderm, Inc. BiotechnologyHealth Technology Operates as a clinical stage biotech company which develops topical PKC-beta inhibitor | Directeur Général | - |
SonALAsense, Inc.
 SonALAsense, Inc. Medical SpecialtiesHealth Technology Operates as a clinical-stage biotechnology company focused on developing a new cancer treatment | Directeur Général | 01/01/2022 |
SeylanMED, Inc.
 SeylanMED, Inc. BiotechnologyHealth Technology Develops targeted therapies for seborrheic keratosis | Directeur Général | - |
Phoenicis Therapeutics, Inc.
 Phoenicis Therapeutics, Inc. BiotechnologyHealth Technology Engages in developing therapeutic | Directeur/Membre du Conseil | - |
Anciens postes connus de Mark de Souza
| Sociétés | Poste | Fin |
|---|---|---|
NFlection Therapeutics, Inc.
 NFlection Therapeutics, Inc. BiotechnologyHealth Technology Operates biopharmaceutical company | Fondateur | 01/06/2022 |
NF2 Therapeutics, Inc.
 NF2 Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Develops therapies | Fondateur | - |
Wings Therapeutics, Inc.
 Wings Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops transformational therapy drugs for healing and integrity of skin diseases | Président | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
1
Relations au 1er degré
9
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 9 |
|---|---|
Chromaderm, Inc.
Chromaderm, Inc. BiotechnologyHealth Technology Operates as a clinical stage biotech company which develops topical PKC-beta inhibitor | Health Technology |
NFlection Therapeutics, Inc.
NFlection Therapeutics, Inc. BiotechnologyHealth Technology Operates biopharmaceutical company | Health Technology |
FIBRX Derm, Inc.
FIBRX Derm, Inc. Pharmaceuticals: MajorHealth Technology Develops anti-scarring therapeutic for patients with skin diseases | Health Technology |
Wings Therapeutics, Inc.
Wings Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops transformational therapy drugs for healing and integrity of skin diseases | Health Technology |
SeylanMED LLC
SeylanMED LLC Miscellaneous Commercial ServicesCommercial Services Develops a therapy for seborrheic keratosis | Commercial Services |
SonALAsense, Inc.
SonALAsense, Inc. Medical SpecialtiesHealth Technology Operates as a clinical-stage biotechnology company focused on developing a new cancer treatment | Health Technology |
SeylanMED, Inc.
SeylanMED, Inc. BiotechnologyHealth Technology Develops targeted therapies for seborrheic keratosis | Health Technology |
Phoenicis Therapeutics, Inc.
Phoenicis Therapeutics, Inc. BiotechnologyHealth Technology Engages in developing therapeutic | Health Technology |
NF2 Therapeutics, Inc.
NF2 Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Develops therapies | Commercial Services |
